Systems and Methods for Active Surveillance for Prostate Cancer

• 1. 用于主动监控前列腺癌的组合物和方法 [P] . 中国专利： CN107530412A . 2018-01-02
• 2. 用于评价前列腺癌进度的分析方法、前列腺癌进度的评价方法、前列腺癌的检测方法以及检查试剂盒 [P] . 中国专利： CN105102986A . 2015-11-25
• 3. COMPOSITIONS AND METHODS FOR ACTIVE SURVEILLANCE OF PROSTATE CANCER. [P] . MX2017013881A . 2018-03-12

  机译： 用于前列腺癌的主动监视的组合物和方法。

• 4. Compositions and Methods for Active Surveillance for Prostate Cancer [P] . PE9302018A1 . 2018-06-08

  机译： 前列腺癌主动监测的组成和方法

• 5. COMPOSITIONS AND METHODS FOR ACTIVE SURVEILLANCE OF PROSTATE CANCER [P] . 欧洲知识产权局专利： EP3287786A3 . 2018-03-21

  机译： 前列腺癌主动监测的组合物和方法

• 1. Tools to identify the men with prostate cancer most appropriate for active surveillance? [J] . Robert H Getzenberg 亚洲男性学杂志（英文版） . 2014,第001期
• 2. PSA-based prostate cancer screening： the role of active surveillance and informed and shared decision making [J] . Lionne D F Venderbos, Monique J Roobol 亚洲男性学杂志：英文版 . 2011,第002期
• 3. Active Surveillance Use Among a Low-risk Prostate Cancer Population in a Large US Payer System: 17-Gene Genomic Prostate Score Versus Other Risk Stratification Methods [J] . Steven Canfield, Michael J. Kemeter, John Hornberger, Reviews in Urology . 2017,第4期
• 4. Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts [J] . Drost Frank Jan H., Nieboer Daan, Morgan Todd M., European urology . 2019,第5期
• 5. Active surveillance or prostate cancer [Surveillance active des cancers de prostate] [J] . MottetN. Oncologie. . 2012,第2期
• 6. The Emerging Role of Biomarkers to Improve Active Surveillance for Low-Risk Prostate Cancer [C] . Matthew R. Cooperberg Genitourinary Cancers Symposium . 2013
• 7. The accuracy of prostate biopsy to assign patients with low-grade prostate cancer to active surveillance. [D] . Ghleilib, Intisar. 2014
• 8. Active Surveillance Use Among a Low-risk Prostate Cancer Population in a Large US Payer System: 17-Gene Genomic Prostate Score Versus Other Risk Stratification Methods [O] . Steven Canfield, Michael J. Kemeter, John Hornberger, 2017
• 9. LBA18 IMPACT OF TRANSIENT ANDROGEN DEPRIVATION THERAPY (ADT) WITH LEUPRORELIN LP 11.25 MG ON THE HISTOLOGICAL PROGRESSION OF INDOLENT PROSTATE CANCER (PC)–RESULTS OF A PHASE III TRIAL VERSUS ACTIVE SURVEILLANCE (AS)IMPACT OF TRANSIENT ANDROGEN DEPRIVATION THERAPY (ADT) WITH LEUPRORELIN LP 11.25 MG ON THE HISTOLOGICAL PROGRESSION OF INDOLENT PROSTATE CANCER (PC)–RESULTS OF A PHASE III TRIAL VERSUS ACTIVE SURVEILLANCE (AS) [O] . Olivier Cussenot, Raphaele Renard Penna, Eva Comperat, 2018

• 1. Expending the Paradigm: Active Surveillance for Intermediate Risk Prostate Cancer [J] . Mohamed Jalloh ,Mamadou Tieoule Traore ,Thierno Amadou Diallo . 泌尿学期刊（英文） . 2018,第8期
• 2. Role of serial multiparametric magnetic resonance imaging in prostate cancer active surveillance [J] . Larissa J Vos ,Michele Janoski ,Keith Wachowicz . 世界放射学杂志：英文版（电子版） . 2016,第4期
• 3. Biochemical recurrence of pathological T2+localized prostate cancer after robotic-assisted radical prostatectomy:A 10-year surveillance [J] . Che Hseuh Yang ,Yi Sheng Lin ,Yen Chuan Ou . 世界临床病例杂志 . 2021,第005期
• 4. 关于大客户主动式监测系统的部署研究 [C] . 李伟哲 ,赵晨笛 ,邓伟东 . 2019广东通信青年论坛 . 2019
• 5. PSMA靶向的纳米主动靶向给药系统构建及其抗前列腺癌作用研究 [A] . 武鑫 . 2012